Return-Path: <bounce-mc.us2_5169274.1460299-3507c8b6d9@mail115.suw13.rsgsv.net>
Received: from gator4148.hostgator.com
	by gator4148.hostgator.com with LMTP
	id sCfhD5H3a2PQBAMA7/vpDg
	(envelope-from <bounce-mc.us2_5169274.1460299-3507c8b6d9@mail115.suw13.rsgsv.net>); Wed, 09 Nov 2022 12:55:13 -0600
Return-path: <bounce-mc.us2_5169274.1460299-3507c8b6d9@mail115.suw13.rsgsv.net>
Envelope-to: gloria@caldonbiotech.com
Delivery-date: Wed, 09 Nov 2022 12:55:13 -0600
Received: from mail115.suw13.rsgsv.net ([198.2.183.115]:40934)
	by gator4148.hostgator.com with esmtps  (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
	(Exim 4.95)
	(envelope-from <bounce-mc.us2_5169274.1460299-3507c8b6d9@mail115.suw13.rsgsv.net>)
	id 1osqEC-001pIj-SX
	for gloria@caldonbiotech.com;
	Wed, 09 Nov 2022 12:55:13 -0600
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=captodayonline.com;
	s=k1; t=1668020102; x=1668322502; i=noreply@captodayonline.com;
	bh=Cfh1R22FoI/IEMJR1yvMcJWRZwTz1oS0y1Th0HGJsTw=;
	h=Subject:From:Reply-To:To:Date:Message-ID:X-MC-User:Feedback-ID:
	 List-ID:List-Unsubscribe:List-Unsubscribe-Post:Content-Type:
	 MIME-Version:CC:Date:Subject:From;
	b=LTlW4m5i9KET3vPruXgLvoPNgA23evnlIIfHjAMXWU4h0HdAs13sMYJIDjMa5WsC4
	 zQuaa59/UarW11x4K3VoRye9hcktsBcoeFe4th59OKwaM59SoXUFEbpEZwbk/fBRt+
	 /On3IBCT51Mbjio0l6V/44Scw36vCmoSJGis9gDk=
Received: from localhost (localhost [127.0.0.1])
	by mail115.suw13.rsgsv.net (Mailchimp) with ESMTP id 4N6vKf2GzTz364WkZ
	for <gloria@caldonbiotech.com>; Wed,  9 Nov 2022 18:55:02 +0000 (GMT)
Subject: =?utf-8?Q?Scoring=20HER2=20expression=20across=20the=20full=20spectrum?=
From: =?utf-8?Q?CAP=20TODAY?= <noreply@captodayonline.com>
Reply-To: =?utf-8?Q?CAP=20TODAY?= <noreply@captodayonline.com>
To: =?utf-8?Q?Gloria=20Milich?= <gloria@caldonbiotech.com>
Date: Wed,  9 Nov 2022 18:55:00 +0000
Message-ID: <93f21bea2e282733bd0cd8d59.3507c8b6d9.20221109185451.f457b5a349.20a8c1c4@mail115.suw13.rsgsv.net>
X-Mailer: Mailchimp Mailer - **CIDf457b5a3493507c8b6d9**
X-Campaign: mailchimp93f21bea2e282733bd0cd8d59.f457b5a349
X-campaignid: mailchimp93f21bea2e282733bd0cd8d59.f457b5a349
X-Report-Abuse: Please report abuse for this campaign here: https://mailchimp.com/contact/abuse/?u=93f21bea2e282733bd0cd8d59&id=f457b5a349&e=3507c8b6d9
X-MC-User: 93f21bea2e282733bd0cd8d59
Feedback-ID: 5169274:5169274.1460299:us2:mc
List-ID: 93f21bea2e282733bd0cd8d59mc list <93f21bea2e282733bd0cd8d59.778753.list-id.mcsv.net>
X-Accounttype: pr
List-Unsubscribe: <https://captodayonline.us2.list-manage.com/unsubscribe?u=93f21bea2e282733bd0cd8d59&id=1abd017e9e&e=3507c8b6d9&c=f457b5a349>, <mailto:unsubscribe-mc.us2_93f21bea2e282733bd0cd8d59.f457b5a349-3507c8b6d9@unsubscribe.mailchimpapp.net?subject=unsubscribe>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
Content-Type: multipart/alternative; boundary="_----------=_MCPart_920419066"
MIME-Version: 1.0
X-Spam-Status: No, score=2.5
X-Spam-Score: 25
X-Spam-Bar: ++
X-Spam-Flag: NO

This is a multi-part message in MIME format

--_----------=_MCPart_920419066
Content-Type: text/plain; charset="utf-8"; format="fixed"
Content-Transfer-Encoding: quoted-printable

HER2-low breast cancers are now of greater clinical interest=2C given Enhe=
rtu=E2=80=99s recent approval for use in treating such cancers.

https://www.captodayonline.com


** Scoring HER2 expression across the full spectrum (https://www.captodayo=
nline.com/scoring-her2-expression-across-the-full-spectrum/)
------------------------------------------------------------
HER2-low breast cancers are now of greater clinical interest=2C given Enhe=
rtu=E2=80=99s recent approval for use in treating such cancers. How to ach=
ieve accurate and reproducible results in scoring HER2-low tumors was at t=
he center of a CAP TODAY webinar on new perspectives on the full spectrum=
 of HER2 expression in breast cancer.

------------------------------------------------------------
https://www.corelaboratory.abbott/int/en/offerings/category/hematology
Q&A column (https://www.captodayonline.com/qa-column-1022/) Q. How useful=
 is an APTT value if the value falls below the reference interval?
A. Any abnormal activated partial thromboplastin time=2C even one that is=
 accelerated or shortened to below a laboratory=E2=80=99s reference range=
=2C is potentially useful. An accelerated APTT can be due to sample collec=
tion (artificial activation of clot formation)=2C a hemolyzed sample (when=
 using mechanical clot detection)=2C overt or non-overt disseminated intra=
vascular coagulation (in vivo activation of clot formation)=2C and elevate=
d factor VIII levels.
------------------------------------------------------------


** Anatomic pathology abstracts
Differentiating between interval appendicitis and acute appendicitis based=
 on histological findings (https://www.captodayonline.com/anatomic-patholo=
gy-selected-abstracts-1022/)
------------------------------------------------------------
While many patients presenting with clinical signs and symptoms of acute a=
ppendicitis undergo surgical intervention shortly after presentation=2C so=
me are initially managed without surgical intervention and undergo appende=
ctomy later. The histology of such interval appendicitis has only been des=
cribed in small series. Furthermore=2C the authors noticed a recent increa=
se in interval appendicitis specimens at their institution. The authors id=
entified appendectomy specimens at their institution during 2018 via H&E s=
lides and electronic medical records and evaluated the cases based on mult=
iple histological findings. Their cohort included 165 patients (125 acute=
 appendicitis and 40 interval appendicitis).

=C2=A9 2022 CAP TODAY=2C all rights reserved. The appearance of advertisin=
g in this message is not a CAP guarantee or endorsement of the product or=
 the claims made for the product by the manufacturer.

This email was sent to gloria@caldonbiotech.com (mailto:gloria@caldonbiotech.com)
why did I get this? (https://captodayonline.us2.list-manage.com/about?u=3D=
93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3Df457b5a349)   =
  unsubscribe from this list (https://captodayonline.us2.list-manage.com/u=
nsubscribe?u=3D93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3D=
f457b5a349)     update subscription preferences (https://captodayonline.us=
2.list-manage.com/profile?u=3D93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=
=3D3507c8b6d9&c=3Df457b5a349)
CAP TODAY . 325 Waukegan Road . Northfield=2C IL 60093 . USA
--_----------=_MCPart_920419066
Content-Type: text/html; charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www=
=2Ew3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!doctype html>
<html>
    <head>
    <meta charset=3D"UTF-8">
    <!-- utf-8 works for most cases -->
    <meta name=3D"viewport" content=3D"width=3Ddevice-width=2C initial-sca=
le=3D1.0">
    <!-- Forcing initial-scale shouldn't be necessary -->
    <meta http-equiv=3D"X-UA-Compatible" content=3D"IE=3Dedge">
    <!-- Use the latest (edge) version of IE rendering engine -->

    <!-- The title tag shows in email notifications=2C like Android 4.4. -=
->
    <!-- Please use an inliner tool to convert all CSS to inline as inpage=
 or external CSS is removed by email clients -->
    <!-- important in CSS is used to prevent the styles of currently inlin=
e CSS from overriding the ones mentioned in media queries when correspondi=
ng screen sizes are encountered -->

    <!-- CSS Reset -->
    <style type=3D"text/css">
/* What it does: Remove spaces around the email design added by some email=
 clients. */
      /* Beware: It can remove the padding / margin and add a background c=
olor to the compose a reply window. */
html=2C  body {
=09margin: 0 !important;
=09padding: 0 !important;
=09height: 100% !important;
=09width: 100% !important;
}
/* What it does: Stops email clients resizing small text. */
* {
=09-ms-text-size-adjust: 100%;
=09-webkit-text-size-adjust: 100%;
}
/* What it does: Forces Outlook.com to display emails full width. */
=2EExternalClass {
=09width: 100%;
}
/* What is does: Centers email on Android 4.4 */
div[style*=3D"margin: 16px 0"] {
=09margin: 0 !important;
}
/* What it does: Stops Outlook from adding extra spacing to tables. */
table=2C  td {
=09mso-table-lspace: 0pt !important;
=09mso-table-rspace: 0pt !important;
}
/* What it does: Fixes webkit padding issue. Fix for Yahoo mail table alig=
nment bug. Applies table-layout to the first 2 tables then removes for any=
thing nested deeper. */
table {
=09border-spacing: 0 !important;
=09border-collapse: collapse !important;
=09table-layout: fixed !important;
=09margin: 0 auto !important;
}
table table table {
=09table-layout: auto;
}
/* What it does: Uses a better rendering method when resizing images in IE=
=2E */
img {
=09-ms-interpolation-mode: bicubic;
}
/* What it does: Overrides styles added when Yahoo's auto-senses a link. *=
/
=2Eyshortcuts a {
=09border-bottom: none !important;
}
/* What it does: Another work-around for iOS meddling in triggered links.=
 */
a[x-apple-data-detectors] {
=09color: inherit !important;
}
</style>

    <!-- Progressive Enhancements -->
    <style type=3D"text/css">
=09=09
=09=09h1 {
=09=09=09font-size:20px;
=09=09=09font-weight:normal;
=09=09=09line-height:25px;
=09=09}
=09=09
=09=09h2 {
=09=09=09font-size:16px;
=09=09=09font-weight:normal;
=09=09=09line-height:22px;
=09=09=09padding-bottom:5px;
=09=09=09margin:0;
=09=09=09
=09=09}
=09=09
=09=09a {
=09=09=09text-decoration:none;
=09=09=09color:#15377e;
=09=09=09padding:0;
=09=09=09margin:0;
=09=09=09
=09=09}

        /* What it does: Hover styles for buttons */
        .button-td=2C
        .button-a {
            transition: all 100ms ease-in;
        }
        .button-td:hover=2C
        .button-a:hover {
            background: #555555 !important;
            border-color: #555555 !important;
        }

        /* Media Queries */
        @media screen and (max-width: 600px) {

            .email-container {
                width: 100% !important;
            }

            /* What it does: Forces elements to resize to the full width o=
f their container. Useful for resizing images beyond their max-width. */
            .fluid=2C
            .fluid-centered {
                max-width: 100% !important;
                height: auto !important;
                margin-left: auto !important;
                margin-right: auto !important;
            }
            /* And center justify these ones. */
            .fluid-centered {
                margin-left: auto !important;
                margin-right: auto !important;
            }

            /* What it does: Forces table cells into full-width rows. */
            .stack-column=2C
            .stack-column-center {
                display: block !important;
                width: 100% !important;
                max-width: 100% !important;
                direction: ltr !important;
            }
            /* And center justify these ones. */
            .stack-column-center {
                text-align: center !important;
=09
            }

            /* What it does: Generic utility class for centering. Useful f=
or images=2C buttons=2C and nested tables. */
            .center-on-narrow {
                text-align: left !important;
                display: block !important;
                margin-left: auto !important;
                margin-right: auto !important;
                float: none !important;
=09=09=09=09}
            table.center-on-narrow {
                display: inline-block !important;
            }

        }

    </style>
    </head>
    <body bgcolor=3D"#ffffff" width=3D"100%" style=3D"margin: 0;" yahoo=3D=
"yahoo">
    <table bgcolor=3D"#ffffff" cellpadding=3D"0" cellspacing=3D"0" border=
=3D"0" height=3D"100%" width=3D"100%" style=3D"border-collapse:collapse;">
      <tr>
        <td><center style=3D"width: 100%;">

            <!-- Visually Hidden Preheader Text : BEGIN -->
            <div style=3D"display:none;font-size:1px;line-height:1px;max-h=
eight:0px;max-width:0px;opacity:0;overflow:hidden;mso-hide:all;font-family=
: sans-serif;">HER2-low breast cancers are now of greater clinical interes=
t=2C given Enhertu=E2=80=99s recent approval for use in treating such canc=
ers.</div>
            <!-- Visually Hidden Preheader Text : END -->

            <!-- Email Header : BEGIN -->
            <table align=3D"center" width=3D"600" class=3D"email-container=
">
            <tr>
                <td style=3D"padding: 20px 0px 10px 0px; text-align: cente=
r"><a href=3D"https://captodayonline.us2.list-manage.com/track/click?u=3D9=
3f21bea2e282733bd0cd8d59&id=3Dd6c336166a&e=3D3507c8b6d9"><img src=3D"http=
s://www.captodayonline.com/2022/eNEWS/Template/CAPTODAYLogo.jpg" width=3D"=
400" height=3D"102" alt=3D"alt_text" border=3D"0"></a></td>
              </tr>
=09=09=09=09
=09=09=09=09
=09=09=09=09<tr><td style=3D"padding-bottom:10px; text-align: center; font=
-family: sans-serif; font-size: 18px; mso-height-rule: exactly; line-heigh=
t: 18px; color: #555555;"></td></tr>
=09=09=09=09
=09=09=09=09
          </table>
            <!-- Email Header : END -->

            <!-- Email Body : BEGIN -->
            <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" align=
=3D"center" bgcolor=3D"#ffffff" width=3D"600" class=3D"email-container">


            <!-- 1 Column Text : BEGIN -->
            <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"font-famil=
y: sans-serif; font-size: 13px; mso-height-rule: exactly; line-height: 18p=
x; color: #555555; padding: 30px 20px 0px 20px; text-align: left;" class=
=3D"center-on-narrow"><h2><a href=3D"https://captodayonline.us2.list-manag=
e.com/track/click?u=3D93f21bea2e282733bd0cd8d59&id=3Db171dec7af&e=3D3507c8b6d9">Scoring HER2 expression across the full spectrum</a></h2>

HER2-low breast cancers are now of greater clinical interest=2C given Enhe=
rtu=E2=80=99s recent approval for use in treating such cancers. How to ach=
ieve accurate and reproducible results in scoring HER2-low tumors was at t=
he center of a CAP TODAY webinar on new perspectives on the full spectrum=
 of HER2 expression in breast cancer.<br>
<br>

              </td>
              </tr>
=09=09=09=09<tr><td style=3D"padding:0px 20px 0px 20px"><hr style=3D"borde=
r: 1px solid #f4f4f4;"></td></tr>
=09=09=09=09
            <!-- Thumbnail Left=2C Text Right : BEGIN -->
            <tr>
                <td dir=3D"ltr" align=3D"center" valign=3D"top" width=3D"1=
00%" style=3D"padding: 25px 10px 10px 10px;"><table align=3D"center" borde=
r=3D"0" cellpadding=3D"0" cellspacing=3D"0" width=3D"100%">
                    <tr>
                    <td width=3D"56.00%" class=3D"stack-column-center"><ta=
ble align=3D"center" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" widt=
h=3D"100%">
                       <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"padding: 0=
 10px;"><a href=3D"https://captodayonline.us2.list-manage.com/track/click?=
u=3D93f21bea2e282733bd0cd8d59&id=3D046864394d&e=3D3507c8b6d9" target=3D"_=
blank"><img src=3D"https:///www.captodayonline.com/2022/eNEWS/110922_Abbot=
tHematology/banner-300x250.png" width=3D"300" height=3D"250" alt=3D"alt_te=
xt" border=3D"0" class=3D"fluid"></a></td>
                      </tr>
                      </table></td>
                    <td width=3D"44.00%" valign=3D"top" class=3D"stack-col=
umn-center"><table align=3D"center" border=3D"0" cellpadding=3D"0" cellspa=
cing=3D"0" width=3D"100%">
                        <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"font-famil=
y: sans-serif; font-size: 12px; mso-height-rule: exactly; line-height: 18p=
x; color: #555555; padding: 10px; text-align: left;" class=3D"center-on-na=
rrow"><a href=3D"https://captodayonline.us2.list-manage.com/track/click?u=
=3D93f21bea2e282733bd0cd8d59&id=3D334344b150&e=3D3507c8b6d9"><h2>Q&amp;A=
 column</h2></a>
<strong>Q. How useful is an APTT value if the value falls below the refere=
nce interval?</strong><br>
<strong>A.</strong> Any abnormal activated partial thromboplastin time=2C=
 even one that is accelerated or shortened to below a laboratory=E2=80=99s=
 reference range=2C is potentially useful. An accelerated APTT can be due=
 to sample collection (artificial activation of clot formation)=2C a hemol=
yzed sample (when using mechanical clot detection)=2C overt or non-overt d=
isseminated intravascular coagulation (in vivo activation of clot formatio=
n)=2C and elevated factor VIII levels.
                            <br>
                         </td>
                      </tr>
                      </table></td>
                  </tr>
                  </table></td>
              </tr>
            <!-- Thumbnail Left=2C Text Right : END -->
           <tr><td style=3D"padding:10px 20px 0px 20px"><hr style=3D"borde=
r: 1px solid #f4f4f4;"></td></tr>
            <!-- Thumbnail Right=2C Text Left : BEGIN -->
=09=09=09
          <tr>
                        <td dir=3D"ltr" valign=3D"top" style=3D"font-famil=
y: sans-serif; font-size: 13px; mso-height-rule: exactly; line-height: 18p=
x; color: #555555; padding: 10px 20px 0px 20px; text-align: left;" class=
=3D"center-on-narrow"><h2>Anatomic pathology abstracts<br><a href=3D"https=
://captodayonline.us2.list-manage.com/track/click?u=3D93f21bea2e282733bd0c=
d8d59&id=3D7ee05e6d3a&e=3D3507c8b6d9">Differentiating between interval ap=
pendicitis and acute appendicitis based on histological findings</a></h2>

While many patients presenting with clinical signs and symptoms of acute a=
ppendicitis undergo surgical intervention shortly after presentation=2C so=
me are initially managed without surgical intervention and undergo appende=
ctomy later. The histology of such interval appendicitis has only been des=
cribed in small series. Furthermore=2C the authors noticed a recent increa=
se in interval appendicitis specimens at their institution. The authors id=
entified appendectomy specimens at their institution during 2018 via H&amp=
;E slides and electronic medical records and evaluated the cases based on=
 multiple histological findings. Their cohort included 165 patients (125 a=
cute appendicitis and 40 interval appendicitis). <br>
<br>

              </td>
              </tr>
            <!-- Thumbnail Right=2C Text Left : END -->

          </table>
            <!-- Email Body : END -->

            <!-- Email Footer : BEGIN -->
            <table align=3D"center" width=3D"600" class=3D"email-container=
">
            <tr>
                <td style=3D"padding: 40px 10px;width: 100%;font-size: 12p=
x; font-family: sans-serif; mso-height-rule: exactly; line-height:18px; te=
xt-align: center; color: #888888;">

                =C2=A9 2022 CAP TODAY=2C all rights reserved. The appearan=
ce of advertising in this message is not a CAP guarantee or endorsement of=
 the product or the claims made for the product by the manufacturer.<br>
                </td>
              </tr>
          </table>
            <!-- Email Footer : END -->

          </center></td>
      </tr>
    </table>
            <center>
                <br>
                <br>
                <br>
                <br>
                <br>
                <br>
                <table border=3D"0" cellpadding=3D"0" cellspacing=3D"0" wi=
dth=3D"100%" id=3D"canspamBarWrapper" style=3D"background-color:#FFFFFF; b=
order-top:1px solid #E5E5E5;">
                    <tr>
                        <td align=3D"center" valign=3D"top" style=3D"paddi=
ng-top:20px; padding-bottom:20px;">
                            <table border=3D"0" cellpadding=3D"0" cellspac=
ing=3D"0" id=3D"canspamBar">
                                <tr>
                                    <td align=3D"center" valign=3D"top" st=
yle=3D"color:#606060; font-family:Helvetica=2C Arial=2C sans-serif; font-s=
ize:11px; line-height:150%; padding-right:20px; padding-bottom:5px; paddin=
g-left:20px; text-align:center;">
                                        This email was sent to <a href=3D"=
mailto:gloria@caldonbiotech.com" target=3D"_blank" style=3D"color:#404040 !importa=
nt;">gloria@caldonbiotech.com</a>
                                        <br>
                                        <a href=3D"https://captodayonline.=
us2.list-manage.com/about?u=3D93f21bea2e282733bd0cd8d59&id=3D1abd017e9e&e=
=3D3507c8b6d9&c=3Df457b5a349" target=3D"_blank" style=3D"color:#404040 !impo=
rtant;"><em>why did I get this?</em></a>&nbsp;&nbsp;&nbsp;&nbsp;<a href=3D=
"https://captodayonline.us2.list-manage.com/unsubscribe?u=3D93f21bea2e2827=
33bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3Df457b5a349" style=3D"color:#4=
04040 !important;">unsubscribe from this list</a>&nbsp;&nbsp;&nbsp;&nbsp;<=
a href=3D"https://captodayonline.us2.list-manage.com/profile?u=3D93f21bea2=
e282733bd0cd8d59&id=3D1abd017e9e&e=3D3507c8b6d9&c=3Df457b5a349" style=3D"col=
or:#404040 !important;">update subscription preferences</a>
                                        <br>
                                        CAP TODAY &middot; 325 Waukegan Ro=
ad &middot; Northfield=2C IL 60093 &middot; USA
                                        <br>
                                        <br>

                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                </table>
                <style type=3D"text/css">
                    @media only screen and (max-width: 480px){
                        table#canspamBar td{font-size:14px !important;}
                        table#canspamBar td a{display:block !important; ma=
rgin-top:10px !important;}
                    }
                </style>
            </center><img src=3D"https://captodayonline.us2.list-manage.co=
m/track/open.php?u=3D93f21bea2e282733bd0cd8d59&id=3Df457b5a349&e=3D3507c8b6d9" height=3D"1" width=3D"1" alt=3D""></body>
</html>
--_----------=_MCPart_920419066--
